Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1563 of 5804
-
Virtual reality goggles may help kids face the dentist with less fear
Symptom relief CompletedStudying the effect of using virtual reality technique in managing pain, anxiety, and vital signs among pediatric dental patients.
Phase: NA • Sponsor: Latakia University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Heart rhythm showdown: which procedure keeps seniors out of hospital?
Disease control OngoingAs patients age, symptom control and treatment of atrial fibrillation become equally difficult, often leading to increased hospitalization. ABLATE versus PACE is a prospective, randomized clinical trial comparing pacemaker implantation with AV node ablation with pulmonary vein is…
Phase: NA • Sponsor: St. Josefs-Hospital Wiesbaden GmbH • Aim: Disease control
Last updated Jun 26, 2026 17:53 UTC
-
Can intense exercise heal your heart after a heart attack?
Disease control CompletedThis study will investigate the effect of a 12-weeks cardiac rehabilitation training (HIIT, MICT) program on VO2peak and cardiac fibrosis in patients, and evaluate the effects of HIIT on endothelial function, microvascular obstruction, body fat, inflammation, arrhythmia and psych…
Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Healing moms, protecting kids: new therapy targets PTSD to stop maltreatment
Disease control Recruiting nowThe purpose of this study is to assess the efficacy of the combined interventions, Skills Training in Affective and Interpersonal Regulation (STAIR) and Parent-Child Interaction Therapy (PCIT) or P-STAIR, for treating maternal PTSD and reducing maltreatment recidivism.
Phase: NA • Sponsor: New York University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
AI eye exam: could a computer beat your doctor at spotting diabetic blindness?
Diagnosis CompletedBackground: Diabetic retinopathy (DR) is one of the most important causes of blindness worldwide, especially in developed countries. In diabetic patients, periodic examination of the back of the eye using a nonmydriatic camera has been widely demonstrated to be an effective syste…
Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
New procedure aims to stop brain bleeds from coming back
Disease control Recruiting nowEMMA-Can is a prospective cohort study to assess the safety and effectiveness of MMA-embolization for the treatment of CSDH. Hypothesis- EMMA reduces the recurrence rate of CSDH with or without concomitant surgical evacuation.
Phase: NA • Sponsor: University of Manitoba • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study aims to cut back pain and unnecessary care for troops and veterans
Symptom relief OngoingThe RESOLVE trial will provide a pragmatic approach to evaluate whether Physical Therapy Clinical Practice Guideline adherence can reduce pain, disability and downstream healthcare utilization for low back pain within the Departments of Defense and Veterans Affairs healthcare sys…
Phase: NA • Sponsor: Sara Gorczynski • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Can a diabetes drug also protect the heart? new study tests liraglutide
Disease control CompletedThe aim of this study is to screen patients with type 2 diabetes with high risk of cardiovascular disease, and intervene with or without Glucagon like peptide-1 receptor agonists.
Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Virtual reality or electrical stimulation: which boosts stroke arm recovery?
Symptom relief CompletedThis randomized controlled, assessor-blinded study aimed to compare the effects of virtual reality-based mirror therapy (VRBMT) and functional electrical stimulation-assisted cycling (FES-cycling) when combined with conventional rehabilitation on upper extremity recovery in patie…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New study: can upadacitinib ease back pain in axial spondylarthritis?
Disease control CompletedAxial spondyloarthritis (axSpA) is an immune-mediated inflammatory disease primarily affecting the axial skeleton. The most frequent axSpA symptom is chronic, often inflammatory back pain (IBP) that might be difficult to distinguish from other causes of chronic back pain (CBP). M…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart drug tested to fight COVID-19 complications
Disease control TerminatedNon-critical patients, hospitalized within the previous 24 hours who tested positive for COVID-19 and have a prior history of cardiovascular disease (CVD) and/or significant risk factors for CVD will be treated for 28 days.
Phase: PHASE2, PHASE3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for non-verbal kids: play plus speech therapy boosts language
Symptom relief OngoingIn this project, the investigator will test the effect of augmenting an evidence based joint attention intervention (JASPER) with a motor-sound system intervention (PROMPT) compared to JASPER only on speech and language outcomes. The investigator will model change over a year to …
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New peptide drug shows promise for obesity and diabetes in early trial
Disease control CompletedThis is a first-in-human evaluation of CT-388 in a double blind, placebo controlled, randomized, SAD/MAD/MD, safety, tolerance, PK, and PD study when administered as a SC injection in otherwise healthy overweight and obese adult participants and obese participants with T2DM.
Phase: PHASE1 • Sponsor: Carmot Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug combo shows promise for Hard-to-Treat brain cancer
Disease control OngoingBTK inhibition and checkpoint blockade are promising classes of therapy for central nervous system (CNS) lymphoma and have demonstrated efficacy with acceptable toxicity. A multidrug approach may carry a higher chance of durable efficacy in this aggressive disease that carries si…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a bipolar drug lift teen depression? new trial seeks answers
Symptom relief Recruiting nowBipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. The treatment of the depressive episodes of bipolar disorder in the pediatric population has not been as widely studied as t…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Skin test may personalize asthma care for kids
Disease control CompletedThis is a randomized, double-blind, placebo-controlled, crossover study comparing asthma control post treatment in African American/Black and Caucasian/White children in both hyper and hypo responsive HILD (Histamine Lontophoresis with Laser Doppler monitoring) phenotypes with un…
Phase: PHASE3 • Sponsor: Bridgette Jones • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Blood filtering showdown: new hope for GBS patients?
Disease control Recruiting nowThis is an observations study evaluating safety and efficacy of immunoadsorption compared to plasma exchange in Guillain-Barré Syndrome.
Sponsor: University of Ulm • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New CIDP drug shows promise in early trial
Disease control CompletedPrimary Objectives: * Part A: Efficacy of SAR445088 across three subpopulations of CIDP patients: standard of care (SOC)-Treated, SOC-Refractory and SOC-Naive * Part B:Long-term safety and tolerability of SAR445088 in CIDP Secondary Objectives: * Part A: * Safety and tolera…
Phase: PHASE2 • Sponsor: Bioverativ, a Sanofi company • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Migraine drug rimegepant tested for safety in kids and teens
Symptom relief Recruiting nowThe purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of age).
Phase: PHASE3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New hope for kids with Cushing's: drug trial launches
Disease control Recruiting nowMulticenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent patients with Cushing's syndrome.
Phase: PHASE2 • Sponsor: RECORDATI GROUP • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC